Statement Of Cash Flows [Abstract]

BioInvent International - Filing #678852

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
331 546 SEK
34 452 SEK
Increase (decrease) in working capital
10 145 SEK
6 775 SEK
Adjustments for decrease (increase) in trade and other receivables
2 353 SEK
38 733 SEK
Adjustments for increase (decrease) in trade and other payables
12 160 SEK
26 616 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of financial instruments, classified as investing activities
72 985 SEK
616 471 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.